Cite Filings / TRDA / 0001950047-24-005356

Feed Companies Filings Check

Sign in

144

Sale of Securities

Entrada Therapeutics, Inc. Filed 2024-07-12 Acc 0001950047-24-005356

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2024-07-16 4 Chief Scientific Officer sold 1,238 shares at $18.00 ($22,284)
2024-07-16 4 CEO sold 1,900 shares at an average $17.84 ($33,897)
2024-07-15 144 Sale of Securities
2024-07-12 144 Sale of Securities
2024-07-10 4 Chief Financial Officer sold 1,758 shares at $14.95 ($26,282)
2024-07-08 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…